Treatment options for diabetic foot osteomyelitis

Area of Science:

• Diabetic Foot Osteomyelitis Management
• Infectious Diseases
• Surgical and Medical Interventions

Background:

• Diabetic foot osteomyelitis (DFO) treatment traditionally involves antibiotics and surgical bone resection.
• Current DFO management requires a tailored, complementary approach integrating both surgical and medical strategies.
• Emerging antibiotic resistance, particularly in Gram-negative rods, complicates DFO treatment.

Purpose of the Study:

• To review recent guidelines from IDSA and IWGDF on DFO management.
• To synthesize current literature on DFO treatment strategies.
• To discuss the evolving role of medical versus surgical interventions for DFO.

Main Methods:

• Literature search of PubMed and Medline using terms 'diabetic foot osteomyelitis' and 'treatment/therapy/therapeutical'.
• Focus on studies published within the last five years.
• Analysis of current guidelines from the Infectious Diseases Society of America (IDSA) and the International Working Group on the Diabetic Foot (IWGDF).

Main Results:

• Surgical resection was historically the standard, but medical management is now effective in select DFO cases.
• Gram-negative bacteria resistance to antibiotics is increasing.
• This resistance trend may reduce the efficacy of medical DFO treatments and worsen patient outcomes.

Conclusions:

• DFO management necessitates a personalized strategy combining surgical and medical options.
• Increasing antibiotic resistance poses a significant challenge to the future medical management of DFO.
• The evolving landscape of bacterial resistance may shift the balance back towards surgical interventions for DFO.